1. Home
  2. Stocks
  3. Lalpathlab Share Price

Dr. Lal Pathlabs Share Price

Healthcare Large Cap

₹3,070.90 -1.6 (-0.05%)

05 Nov, 2024 22:15

SIP TrendupStart SIP in LALPATHLAB

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹3,041
  • High
  • ₹3,105
  • 52 Week Low
  • ₹1,944
  • 52 Week High
  • ₹3,654
  • Open Price₹3,065
  • Previous Close₹3,073
  • Volume101,631

Investment Returns

  • Over 1 Month -12.14%
  • Over 3 Month -0.83%
  • Over 6 Month + 32.46%
  • Over 1 Year + 18.36%
SIP Lightning

Smart Investing Starts Here Start SIP with Dr. Lal Pathlabs for Steady Growth!

Dr. Lal Pathlabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 63.9
  • PEG Ratio
  • 1.9
  • Market Cap Cr
  • 25,666
  • P/B Ratio
  • 13.6
  • Average True Range
  • 95.43
  • EPS
  • 46
  • Dividend Yield
  • 1
  • MACD Signal
  • -61.94
  • RSI
  • 36.75
  • MFI
  • 16.55

Dr. Lal Pathlabs Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations583.90534.50479.00476.00531.70
Total Income From Operations583.90534.50479.00476.00531.70
P/L Before Interest, Excpt. Items & Tax188.30166.50126.40126.00158.00
P/L Before Exceptional Items & Tax183.30161.00120.50119.50150.90
P/L After Tax from Ordinary Activities135.20122.9089.5088.30113.00
Net Profit/Loss For the Period135.20122.9089.5088.30113.00
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,966.621,768.79
Revenue From Operations [Net]1,966.621,768.79
Total Operating Revenues1,966.761,769.03
Total Revenue2,026.861,815.63
Total Expenses1,510.891,424.80
Profit/Loss Before Tax515.97390.83
Profit/Loss For The Period384.37292.36
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity477.60427.53
Net Cash Used In Investing Activity31.91-288.47
Net Cash Used in Finance Activity-404.00-270.05
Net Inc/Dec In Cash And Equivalent105.51-130.99
Cash And Equivalent End Of Year325.83220.32
IndicatorMar 24Mar 23
Total Share Capital83.4883.37
Total Non-Current Liabilities91.34198.15
Total Current Liabilities424.44432.16
Total Capital And Liabilities2,415.442,320.17
Total Non-Current Assets1,494.891,510.00
Total Current Assets920.55810.17
Total Assets2,415.442,320.17
Indicator20242023
EBIT Margin (%)27.5924.03
Return On Capital Employed (%)27.2622.52
Return On Equity (%)20.2317.30
Long Term Debt To Equity (%)0.004.93
Book Value/Share (INR)227.56202.70
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations660.20601.90545.40538.90601.30
Total Income From Operations660.20601.90545.40538.90601.30
P/L Before Interest, Excpt. Items & Tax189.10155.90126.50122.90160.00
P/L Before Exceptional Items & Tax183.10149.90119.90115.90152.20
P/L After Tax from Ordinary Activities130.80107.8085.8082.20110.70
Net Profit/Loss For the Period130.80107.8085.8082.20110.70
IndicatorMar 24Mar 23
Revenue From Operations [Gross]2,226.502,016.64
Revenue From Operations [Net]2,226.502,016.64
Total Operating Revenues2,226.642,016.88
Total Revenue2,295.812,058.60
Total Expenses1,790.361,714.77
Profit/Loss Before Tax505.45343.83
Profit/Loss For The Period362.29241.08
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity535.33456.03
Net Cash Used In Investing Activity-24.27-287.31
Net Cash Used in Finance Activity-413.86-283.18
Net Inc/Dec In Cash And Equivalent97.20-114.46
Cash And Equivalent End Of Year360.93263.73
IndicatorMar 24Mar 23
Total Share Capital83.4883.37
Total Non-Current Liabilities105.41216.26
Total Current Liabilities465.19469.75
Total Capital And Liabilities2,455.962,385.56
Total Non-Current Assets1,329.271,412.48
Total Current Assets1,126.70973.09
Total Assets2,455.962,385.56
Indicator20242023
EBIT Margin (%)24.0118.90
Return On Capital Employed (%)26.8619.90
Return On Equity (%)19.3414.33
Long Term Debt To Equity (%)0.005.00
Book Value/Share (INR)225.85203.86

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹3,070.90
-1.6 (-0.05%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹3,196.97
  • 50 Day
  • ₹3,240.36
  • 100 Day
  • ₹3,130.05
  • 200 Day
  • ₹2,914.80

Resistance and Support

3072.42 Pivot Speed
  • R3 3,166.83
  • R2 3,135.87
  • R1 3,103.38
  • S1 3,039.93
  • S2 3,008.97
  • S3 2,976.48

Is Dr. Lal Pathlabs Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Dr. Lal Path Labs Ltd. is one of India’s leading diagnostic and healthcare service providers, offering a wide range of tests and services through a network of over 200 labs and 3,000 patient service centers across the country. Dr Lal Pathlabs has an operating revenue of Rs. 2,346.40 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 23% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 12% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Dr. Lal Pathlabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Quarterly Results & Interim Dividend
2024-08-07 Quarterly Results & Interim Dividend
2024-05-10 Audited Results & Final Dividend
2024-02-01 Quarterly Results & Interim Dividend
2023-11-02 Quarterly Results
Date Purpose Remarks
2024-11-05 INTERIM Rs.6.00 per share(60%)Second Interim Dividend
2024-08-20 INTERIM Rs.6.00 per share(60%)Interim Dividend
2024-06-10 FINAL Rs.6.00 per share(60%)Final Dividend
2024-02-13 INTERIM Rs.12.00 per share(120%)Interim Dividend
2023-08-11 FINAL Rs.6.00 per share(60%)Final Dividend

Dr. Lal Pathlabs F&O

Dr. Lal Pathlabs Shareholding Pattern

53.92%
9.84%
2.54%
26.82%
0%
4.1%
2.78%
  • NSE Symbol
  • LALPATHLAB
  • BSE Symbol
  • 539524
  • Managing Director
  • Dr. Om Prakash Manchanda
  • ISIN
  • INE600L01024

Dr. Lal Pathlabs FAQs

Dr. Lal Pathlabs share price is ₹3,070 As on 05 November, 2024 | 22:01

The Market Cap of Dr. Lal Pathlabs is ₹25666.4 Cr As on 05 November, 2024 | 22:01

The P/E ratio of Dr. Lal Pathlabs is 63.9 As on 05 November, 2024 | 22:01

The PB ratio of Dr. Lal Pathlabs is 13.6 As on 05 November, 2024 | 22:01

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.